CXCL11 and hereditary angioedema: Adding presented results to the evidence generated by other groups, we claim that the role of the BR1 in triggering and/or maintaining HAE symptoms seems to be more important than had been previously believed and further studies on bigger cohorts should be performed, ideally also with antagonists of BR1 given during the HAE attack.